Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Cipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...

Cipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...

Markets faced selling pressure on Tuesday due to weak global cues and macroeconomic concerns, with the Nifty approaching support at 23,150....

Indian stock markets are set for a busy week. Key events like Q4 earnings announcements for many companies will influence trading. Foreign ...

Shares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...

Nifty 50 and BSE Sensex declined, snapping a three-day rally due to IT and FMCG losses. Rising India VIX signaled caution, though broader t...

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...

Cipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamie...

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 124555.61 Crore) operating in Pharmaceuticals ...

Cipla plans acquisitions and inorganic partnerships in the US market while strengthening its presence in the domestic market. The company a...

However, the company has issued a clarification, saying that "the company is not aware of any event that requires disclosure under Listing ...

The investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based the...

The total revenue from operations was Rs 5,260.33 crore, up 14.19 per cent from Rs 4,606.45 crore the company reported in the year-ago quar...

Its India business grew by 17 per cent YoY with strong growth across the three businesses and continued servicing of patients with Covid-19...

Though there is a hope of reduction in taxation and direct tax reforms, the weekend statement is getting a lot of HNI community worried, sa...